Related references
Note: Only part of the references are listed.Dose-adapted salvage radiotherapy after radical prostatectomy based on an erMRI target definition model: Toxicity analysis
Thomas Zilli et al.
ACTA ONCOLOGICA (2014)
11C-Choline PET/CT detects the site of relapse in the majority of prostate cancer patients showing biochemical recurrence after EBRT
Francesco Ceci et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2014)
11C-Choline PET/CT Predicts Prostate Cancer-Specific Survival in Patients with Biochemical Failure During Androgen-Deprivation Therapy
Giampiero Giovacchini et al.
JOURNAL OF NUCLEAR MEDICINE (2014)
Salvage Stereotactic Body Radiotherapy for Patients With Limited Prostate Cancer Metastases: Deferring Androgen Deprivation Therapy
Patrick Berkovic et al.
CLINICAL GENITOURINARY CANCER (2013)
11C-Choline PET/CT in patients with hormone-resistant prostate cancer showing biochemical relapse after radical prostatectomy
Francesco Ceci et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2013)
18F-Fluoroethylcholine PET/CT Identifies Lymph Node Metastasis in Patients with Prostate-Specific Antigen Failure After Radical Prostatectomy but Underestimates Its Extent
Derya Tilki et al.
EUROPEAN UROLOGY (2013)
Adjuvant and Salvage Radiotherapy After Prostatectomy: AUA/ASTRO Guideline
Ian M. Thompson et al.
JOURNAL OF UROLOGY (2013)
Clinical impact of 18F-choline PET/CT in patients with recurrent prostate cancer
Jan D. Soyka et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2012)
Postoperative Radiation Therapy for Pathologically Advanced Prostate Cancer After Radical Prostatectomy
Andrew J. Stephenson et al.
EUROPEAN UROLOGY (2012)
Global Cancer Statistics
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2011)
Choline PET/CT for prostate cancer: Main clinical applications
Chiara Fuccio et al.
EUROPEAN JOURNAL OF RADIOLOGY (2011)
Pelvic/Retroperitoneal Salvage Lymph Node Dissection for Patients Treated With Radical Prostatectomy With Biochemical Recurrence and Nodal Recurrence Detected by [11C]Choline Positron Emission Tomography/Computed Tomography
Patrizio Rigatti et al.
EUROPEAN UROLOGY (2011)
EAU Guidelines on Prostate Cancer. Part II: Treatment of Advanced, Relapsing, and Castration-Resistant Prostate Cancer
Nicolas Mottet et al.
EUROPEAN UROLOGY (2011)
[18F]fluoroethylcholine-PET/CT imaging for radiation treatment planning of recurrent and primary prostate cancer with dose escalation to PET/CT-positive lymph nodes
Florian Wuerschmidt et al.
RADIATION ONCOLOGY (2011)
Influence of 11C-choline PET/CT on the treatment planning for salvage radiation therapy in patients with biochemical recurrence of prostate cancer
Michael Souvatzoglou et al.
RADIOTHERAPY AND ONCOLOGY (2011)
PSA doubling time for prediction of [11C]choline PET/CT findings in prostate cancer patients with biochemical failure after radical prostatectomy
Giampiero Giovacchini et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2010)
External irradiation with or without long-term androgen suppression for prostate cancer with high metastatic risk: 10-year results of an EORTC randomised study
Michel Bolla et al.
LANCET ONCOLOGY (2010)
Influence of Trigger PSA and PSA Kinetics on 11C-Choline PET/CT Detection Rate in Patients with Biochemical Relapse After Radical Prostatectomy
Paolo Castellucci et al.
JOURNAL OF NUCLEAR MEDICINE (2009)
A model that predicts the probability of positive imaging in prostate cancer cases with biochemical failure after initial definitive local therapy
Toni K. Choueiri et al.
JOURNAL OF UROLOGY (2008)
The detection rate of [C-11]Choline-PET/CT depends on the serum PSA-value in patients with biochemical recurrence of prostate cancer
B. J. Krause et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2008)
Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy
Andrew J. Stephenson et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of prostate cancer
VV Kataja et al.
ANNALS OF ONCOLOGY (2005)
Recurrence-free survival rates after external-beam radiotherapy for patients with clinical T1-T3 prostate carcinoma in the prostate-specific antigen era - What should we expect?
D Khuntia et al.
CANCER (2004)
Can prostate specific antigen derivatives and pathological parameters predict significant change in expectant management criteria for prostate cancer?
MA Khan et al.
JOURNAL OF UROLOGY (2003)
Time trends in biochemical recurrence after radical prostatectomy: Results of the search database
SJ Freedland et al.
UROLOGY (2003)
A structured debate: Immediate versus deferred androgen suppression in prostate cancer - Evidence for deferred treatment
PC Walsh et al.
JOURNAL OF UROLOGY (2001)
Share Paper
